Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04966351 · ClinicalTrials.gov registry record · NA

Countermeasures to Circadian Misalignment

A NA study of Metabolic Disease and Insulin Sensitivity, sponsored by Colorado State University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT04966351 is a NA study of Metabolic Disease and Insulin Sensitivity that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 32 participants, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04966351, a NA study of Metabolic Disease and Insulin Sensitivity, is actively recruiting participants, sponsored by Colorado State University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable. This project will examine whether avoiding food intake during the biological night can mitigate the impact of circadian misalignment on metabolic homeostasis in adults during simulated night shift work. Findings from this study could identify a translatable strategy to minimize metabolic diseases in populations that include anyone working nonstandard hours such as police, paramedics, firefighters, military personnel, pilots, doctors and nurses, truck drivers, and individuals with sleep disorders.

Interventions

  • BEHAVIORAL Time-restricted feeding
  • BEHAVIORAL Circadian Misalignment

Study Locations (1)

Colorado

  • Colorado State University - Fort Collins

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-07-07
Est. Completion 2026-06-30
Phase NA

Sponsor

Colorado State University

94 total trials

What the Registry Record Tells You About NCT04966351

The ClinicalTrials.gov registry entry for NCT04966351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower). The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Metabolic Disease appearing as the primary indexed condition, and to 2 interventions - of which Time-restricted feeding is the first listed.

NCT04966351 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04966351 about?

NCT04966351 is a clinical study titled "Countermeasures to Circadian Misalignment". Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable. This project will examine whether avoiding food intake during the biological night ...

What is the current status of trial NCT04966351?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2021-07-07. Estimated completion is 2026-06-30.

What conditions does trial NCT04966351 study?

This clinical trial studies the following conditions: Metabolic Disease, Insulin Sensitivity, Circadian Rhythm Sleep Disorder of Shift Work Type.

What interventions are being tested in trial NCT04966351?

The interventions under investigation include: Time-restricted feeding (BEHAVIORAL), Circadian Misalignment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04966351?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04966351 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.